US2001016581A1PendingUtilityA1
Separation of cephalosporin isomers
Priority: Nov 17, 1993Filed: Jan 23, 2001Published: Aug 23, 2001
Est. expiryNov 17, 2013(expired)· nominal 20-yr term from priority
A61P 31/04C07D 501/00
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Process of depleting 7-amino-3-[(E)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid in Z/E mixtures of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid a) by subjecting an amine salt of a Z/E mixture of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid to crystallization and converting this amine salt into 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid, or b) by subjecting the Z/E mixture to chromatography.
Claims
exact text as granted — not AI-modified1 . Process of depleting 7-amino-3-[(E)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid in Z/E mixtures of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid of formula
a) by subjecting an amine salt of a Z/E mixture of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid to crystallization and converting this amine salt into 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid, or b) subjecting the Z/E mixture to chromatography.
2 . The process according to claim 1 a ) in a process for the depletion or separation respectively of the E-isomer in Z/E mixtures of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid by
α) reacting the Z/E mixture of formula I according to claim 1 with an amine of formula NR 1 R 2 R 3 wherein R 1 , R 2 and R 3 are the same or different and independently of one another denote hydrogen, (C 1-8 )alkyl, unsubstituted or substituted benzyl or (C 4-8 )cycloalkyl, or R 1 and R 2 together with the nitrogen atom signify a 5- or 6-membered heterocycle, which may contain one or two further hetero atoms, and R 3 is as defined above, to form a compound of formula
wherein R 1 , R 2 and R 3 are as defined above in a solvent or solvent mixture, in which the Z- and E-isomers of the compound of formula II are soluble to different degrees, or β) a compound of formula II is dissolved or suspended in a solvent or solvent mixture and the solubility product of the isomers of formula II is adjusted, and after isolating the Z-isomer of formula II or the compound of formula II with a low content of E-isomer, this compound is converted with the assistance of an acid into the compound of formula
or into the compound of formula I with a low content of E-isomer.
3 . The process according to claim 1 b ) in a process for the depletion or separation respectively of the E-isomer in Z/E mixtures of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid by means of adsorption chromatography, characterized in that an aqueous solution of the compound of formula I as an ammonium salt or as the salt of an inorganic acid is chromatographed with water or a solvent/water mixture over an adsorber resin or activated carbon, whereby the undesired E-isomer exhibits considerably different retention times when compared with the Z-isomer.
4 . An amine salt of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid.
5 . An amine salt according to claim 4 of formula
wherein R 1 , R 2 and R 3 are the same or different and independently of one another denote hydrogen, (C 1-8 )alkyl, unsubstituted or substituted benzyl or (C 4-8 )cycloalkyl, or R 1 and R 2 together with the nitrogen atom signify a 5- or 6-membered heterocycle, which may contain one or two further hetero atoms, and R 3 is as defined above.
6 . An amine salt according to anyone of claims 4 or 5 , wherein the hydrogen atoms at the C═C bond of the vinyl group have the cis configuration.
7 . An amine salt according to claim 6 which is
7-amino- 3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid dicyclohexylammonium salt or
7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid (2,4,4-trimethylpentyl-2)ammonium salt or
7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid tert. -butylammonium salt.
8 . 7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid and mixtures of 7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid and 7-amino-3-[(E)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid containing 15% and less of the E-isomer.
9 . Use of an amine salt of 7-amino-3-[2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid in the production of cephalosporins.
10 . Use of 7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid or of mixtures of 7-amino-3-[(Z)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid and 7-amino-3-[(E)-2-(4-methyl-5-thiazolyl)vinyl]-3-cephem-4-carboxylic acid containing 15% or less of the E-isomer in the production of cephalosporins.Join the waitlist — get patent alerts
Track US2001016581A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.